Peripheral Inflammatory Markers Contributing to Comorbidities in Autism.

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Autism Spectrum Disorders (ASD) are complex neurodevelopmental conditions.
• Comorbidities and clinical findings in ASD require further investigation.
• Peripheral biomarkers offer a potential avenue for understanding ASD pathophysiology.

Purpose of the Study:

• To evaluate the role of peripheral biomarkers in predicting comorbidities and clinical findings in autism.
• To explore the relationship between cytokine profiles, electroencephalography (EEG) findings, and epilepsy in children with ASD.

Main Methods:

• Study included 17 autistic children and age-matched typically developing controls (3-9 years old).
• Diagnostic criteria followed DSM-IV; severity assessed using CARS.
• Plasma cytokine profiles analyzed via ELISA; EEG records obtained.

Main Results:

• Significant differences in IL-1β, IL-6, IL-17, IL-12p40, and IL-12p70 levels between ASD and control groups (p < 0.05).
• All ASD patients exhibited interictal epileptiform activity on EEG; 37.5% had epilepsy.
• Higher IL-6 levels correlated with frontal interictal epileptiform activity in ASD patients without epilepsy (p < 0.05).

Conclusions:

• Peripheral inflammatory markers may serve as predictive biomarkers for ASD comorbidities.
• These biomarkers can enhance interpretation of EEG findings in children with ASD.
• Biomarker analysis aids informed clinical decision-making for ASD management.